Developing new tools to visualize cell signaling in cancer
Dynamic probes of endogenous protein aggregation and cell signaling
This study is working on new tools to help scientists see how certain proteins in our cells communicate, especially in relation to cancer, which could lead to better treatments for patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10890825 on NIH RePORTER |
What this research studies
This research focuses on creating innovative molecular probes that can accurately visualize and manipulate the dynamics of cell signaling, particularly the Wnt/β-catenin pathway, which is crucial in cancer development. By developing a novel fluorescent biosensor, the project aims to observe how proteins aggregate and signal within cells without altering their natural state. This approach allows for real-time monitoring of cellular processes, which could lead to a better understanding of cancer biology and potential therapeutic targets. Patients may benefit from insights gained through this research that could inform future treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancers that involve the Wnt/β-catenin signaling pathway.
Not a fit: Patients with cancers unrelated to the Wnt/β-catenin pathway may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for various cancers by providing insights into cell signaling mechanisms.
How similar studies have performed: Other research has shown success in developing biosensors for cell signaling, indicating that this approach has potential for impactful results.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Bugaj, Lukasz — University of Pennsylvania
- Study coordinator: Bugaj, Lukasz
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.